PIII vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 17, 2026

PIII

41.3
AI Score
VS
PACS Wins

PACS

54.1
AI Score

Investment Advisor Scores

PIII

41score
Recommendation
HOLD

PACS

54score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric PIII PACS Winner
Revenue 772.77M 2.85B PACS
Net Income 8.67M 157.06M PACS
Net Margin 1.1% 5.5% PACS
Operating Income 49.46M 229.37M PACS
ROE 11.8% 14.1% PACS
ROA 1.3% 2.8% PACS
Total Assets 654.39M 5.66B PACS
Cash 21.27M 164.45M PACS
Debt/Equity 1.64 0.21 PACS
Current Ratio 0.46 0.91 PACS

Relative Price Performance (Last 90 Days)

PIII 1M: +10.7% · 3M: -25.6% PACS 1M: -1.3% · 3M: +17.2%

Current Technical Phase

PIII

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 47.2 · Price: $10.31

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.6 · Price: $44.25

Fundamentals Snapshot

Metric PIII PACS
Market Cap
Forward P/E -1.0 16.3
Trailing P/E 25.5
Revenue (TTM)
Revenue Growth 0.1% 0.1%
Gross Margin 0.0% 0.2%
Operating Margin 0.1% 0.1%
EPS -31.16 1.71
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate, winning 10 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.